Southern Star Research Logo

Meet us at BIO International Convention

June 16-19, 2025
Boston, USA
Home Events

Come and meet us

Our team will be available throughout this event to discuss how we can support your research initiatives. Whether you’re looking to start a new project, save an existing one or simply explore new partnership opportunities, we’re here to help.

Dr David Lloyd

Managing Director

Dan Evans

Daniel Evans

Director, Business Development

Rob Kent

Robert Kent

Senior Director, Business Development

Southern Star Research at BIO International Convention 2025

Southern Star Research is excited to attend the BIO International Convention 2025 in Boston—the world’s largest gathering of biotechnology leaders, representing the full global ecosystem of innovation, investment, and opportunity.

With a strong local and global presence, Southern Star Research delivers tailored support to early-phase biotech companies looking to grow, scale, and attract investment. Whether you’re an investor, financial advisor, or an emerging biotech leader, our team is ready to connect and collaborate.

Why Meet with Southern Star Research at BIO 2025?

  • Strategic insights tailored for early-phase biotech in the US
  • Proven frameworks that help startups scale, meet milestones, and attract funding
  • A global perspective with a deep understanding of US market dynamics
  • The Australian Advantage – leverage Australia’s fast, cost-effective, and globally recognized clinical research environment

📍 Let’s connect in Boston
Join us from June 16–19 at BIO 2025 and discover how Southern Star Research can support your clinical trials plans. Fill out the form below to schedule a meeting with our team.

Schedule a meeting

Bio USA 2025 GF

"*" indicates required fields

Southern Star Research values your privacy and is committed to protecting your personal information. We’ll only use your details for essential communications related to your account. From time to time, we’d like to share updates about our latest news, research, and other content that may interest you.

The Australian Advantage

Cost

Eligible organisations receive a 43.5% cash rebate on trial costs with the Australian Research & Development tax incentive.

Speed

Get you trial up and running in 8 weeks with streamlined ethics approvals and no need for an Investigational New Drug application.

Quality

World-class healthcare facilities and renowned experts ensure your data is accepted by international regulatory bodies like the FDA and EMA.
Head Office:
Phone: +61 2 9011 6266

L1, 1 Merriwa Street,

Gordon, NSW, 2072 Australia

E: info@southernstarresearch.com 

Connect with us
About Us Services Careers News Contact Us
Early Phase Specialist CRO Clinical Operations Biometrics Safety and Medical Monitoring Medical Writing

Sign up to our newsletter

Keep up to date with the latest news, updates and promotions

"*" indicates required fields

Southern Star Research values your privacy and is committed to protecting your personal information. We’ll only use your details for essential communications related to your account. From time to time, we’d like to share updates about our latest news, research, and other content that may interest you.

By clicking 'SUBSCRIBE NOW', you agree that Southern Star Research may collect and use your personal data for these marketing and communication purposes.

Copyright 2026 Southern Star Research Pty Ltd

Privacy Policy Legal Notice
icon of a head

Specialist experience

Each member of our Leadership Team boasts an average of 30 years experience. Our clients have access to an extraordinary group of Clinical Research professionals, whose experience covers Multinational Pharmaceutical companies, Biotechnology, Medical Device, CRO’s, research institutes, Universities, Industry Associations & Government Bodies. Together, we ensure that every aspect of your unique and novel drug study  clinical trial is handled with scientific precision, care, and foresight.

Our team has all of the tools, knowledge and experience to solve almost any issue that may arise during the complex clinical trial process.

We recognize that each study is unique and different and there are nuances that need to be resolved proactively.

Our advisory board of top-tier specialists in multiple therapeutic areas engage in the early stages from protocol design in constructive discussions to anticipate challenges and enhance study efficiency throughout the study.